When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

In a heartfelt moment of sorrow, Prince William finds himself mourning the loss of one of his closest friends, Zach Stubbings ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

According to The Daily Mail, Zach Stubbings —a former flight sergeant and helicopter winchman—was diagnosed with multiple ...

Zach Stubbings was diagnosed with multiple myeloma, cancer of the blood and bone marrow, in 2013, thirteen years after ...

PRINCE William’s military flying instructor has died of cancer after years of exposure to toxic helicopter exhaust fumes.

How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4 ... a potential treatment for Sandhoff and Tay-Sachs diseases -- two rare, often fatal lysosomal storage disorders that ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.